WallStreetZenWallStreetZen

NASDAQ: AMGN
Amgen Inc Stock Forecast, Predictions & Price Target

Open Broker Account
OverviewForecast
EarningsDividendOwnership

Analyst price target for AMGN

Based on 14 analysts offering 12 month price targets for Amgen Inc.
Min Forecast
$182.00-19.25%
Avg Forecast
$239.50+6.26%
Max Forecast
$290.00+28.66%

Should I buy or sell AMGN stock?

Based on 14 analysts offering ratings for Amgen Inc.
Hold
Strong Buy
2 analysts 14.29%
Buy
1 analysts 7.14%
Hold
10 analysts 71.43%
Sell
0 analysts 0%
Strong Sell
1 analysts 7.14%

Be the first to know when Wall Street analysts revise their AMGN stock forecasts and price targets.

AMGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Atlantic Equities
Bottom 30%
30
Strong SellMaintains$182.00-19.25%2022-08-09
RBC Capital
Bottom 25%
25
HoldMaintains$236.00+4.70%2022-08-05
Piper Sandler
Bottom 25%
25
Strong BuyMaintains$265.00+17.57%2022-08-05
Morgan Stanley
Bottom 2%
2
HoldMaintains$253.00+12.24%2022-07-15
Oppenheimer
Top 7%
94
BuyMaintains$290.00+28.66%2022-06-01
SVB Leerink
Top 13%
88
HoldInitiates Coverage On$256.00+13.58%2022-05-23
Mizuho
Bottom 19%
19
HoldMaintains$208.00-7.72%2022-05-10
RBC Capital
Bottom 27%
27
HoldMaintains$223.00-1.06%2022-04-28
Anonymous
BMO Capital
HoldMaintains$243.00+7.81%2022-04-28
Wells Fargo
Top 14%
87
HoldMaintains$250.00+10.91%2022-02-09

1 of 2

Forecast return on equity

Is AMGN forecast to generate an efficient return?
Company
463.06%
Industry
91.67%
Market
121.74%
AMGN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AMGN forecast to generate an efficient return on assets?
Company
18.89%
Industry
17.84%
AMGN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AMGN earnings per share forecast

What is AMGN's earnings per share in the next 3 years based on estimates from 13 analysts?
Avg 1 year Forecast
$17.45+47.51%
Avg 2 year Forecast
$19.12+61.62%
Avg 3 year Forecast
$20.98+77.35%
AMGN's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

AMGN revenue forecast

What is AMGN's revenue in the next 3 years based on estimates from 10 analysts?
Avg 1 year Forecast
$26.1B-0.89%
Avg 2 year Forecast
$27.4B+3.82%
Avg 3 year Forecast
$28.9B+9.35%
AMGN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AMGN earnings growth forecast

How is AMGN forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
20.97%
Industry
13.64%
Market
16.88%
AMGN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
AMGN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
AMGN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

AMGN revenue growth forecast

How is AMGN forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
3.03%
Industry
0.94%
Market
8.59%
AMGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AMGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AMGN vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
AMGN$225.40$239.50+6.26%Hold
SNY$38.02N/AN/AHold
BMY$71.09$75.90+6.77%Buy
GILD$61.69$71.15+15.34%Hold
NVS$76.01N/AN/AHold
View Top General Drug Manufacturer Stocks

Amgen Stock Forecast FAQ

Is Amgen Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 14 Wall Street analysts covering (NASDAQ: AMGN) stock is to Hold AMGN stock.

Out of 14 analysts, 2 (14.29%) are recommending AMGN as a Strong Buy, 1 (7.14%) are recommending AMGN as a Buy, 10 (71.43%) are recommending AMGN as a Hold, 0 (0%) are recommending AMGN as a Sell, and 1 (7.14%) are recommending AMGN as a Strong Sell.

If you're new to stock investing, here's how to buy Amgen stock.

What is AMGN's earnings growth forecast for 2022-2024?

(NASDAQ: AMGN) Amgen's forecast annual earnings growth rate of 20.97% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 13.64%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 16.88%.

Amgen's earnings in 2022 is $6,576,000,000.On average, 13 Wall Street analysts forecast AMGN's earnings for 2022 to be $9,334,543,333, with the lowest AMGN earnings forecast at $9,120,570,993, and the highest AMGN earnings forecast at $9,548,515,673. On average, 13 Wall Street analysts forecast AMGN's earnings for 2023 to be $10,227,877,852, with the lowest AMGN earnings forecast at $9,575,262,215, and the highest AMGN earnings forecast at $11,094,465,829.

In 2024, AMGN is forecast to generate $11,222,849,233 in earnings, with the lowest earnings forecast at $10,094,145,140 and the highest earnings forecast at $14,394,989,174.

What is AMGN's revenue growth forecast for 2022-2024?

(NASDAQ: AMGN) Amgen's forecast annual revenue growth rate of 3.03% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 0.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.59%.

Amgen's revenue in 2022 is $26,384,000,000.On average, 10 Wall Street analysts forecast AMGN's revenue for 2022 to be $13,988,186,030,554, with the lowest AMGN revenue forecast at $13,867,119,410,720, and the highest AMGN revenue forecast at $14,113,615,546,400. On average, 10 Wall Street analysts forecast AMGN's revenue for 2023 to be $14,652,945,667,710, with the lowest AMGN revenue forecast at $14,098,637,482,600, and the highest AMGN revenue forecast at $15,185,065,991,025.

In 2024, AMGN is forecast to generate $15,433,934,545,024 in revenue, with the lowest revenue forecast at $14,535,675,987,050 and the highest revenue forecast at $17,127,597,831,789.

What is AMGN's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: AMGN) forecast ROA is 18.89%, which is higher than the forecast US Drug Manufacturers - General industry average of 17.84%.

What is AMGN's Price Target?

According to 14 Wall Street analysts that have issued a 1 year AMGN price target, the average AMGN price target is $239.50, with the highest AMGN stock price forecast at $290.00 and the lowest AMGN stock price forecast at $182.00.

On average, Wall Street analysts predict that Amgen's share price could reach $239.50 by Aug 9, 2023. The average Amgen stock price prediction forecasts a potential upside of 6.26% from the current AMGN share price of $225.40.

What is AMGN's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: AMGN) Amgen's current Earnings Per Share (EPS) is $11.83. On average, analysts forecast that AMGN's EPS will be $17.45 for 2022, with the lowest EPS forecast at $17.05, and the highest EPS forecast at $17.85. On average, analysts forecast that AMGN's EPS will be $19.12 for 2023, with the lowest EPS forecast at $17.90, and the highest EPS forecast at $20.74. In 2024, AMGN's EPS is forecast to hit $20.98 (min: $18.87, max: $26.91).

What is AMGN's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: AMGN) forecast ROE is 463.06%, which is considered strong.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market Industries
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.